Digital Human-Based Brief Interventions for Harmful Alcohol Use: The PAHOLA Project
Launched by CENTRE FOR ADDICTION AND MENTAL HEALTH · Jun 7, 2023
Trial Information
Current as of August 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The PAHOLA Project is a clinical trial aimed at helping people in Canada who struggle with harmful alcohol use but may not have access to traditional treatment. The goal is to create a digital health worker named PAHOLA that can provide support and guidance using techniques such as motivational interviewing and cognitive behavioral therapy. This technology aims to reach individuals who might avoid seeking help due to concerns like privacy, stigma, or simply not knowing where to turn for support.
To participate in the trial, you need to be at least 18 years old and currently drink alcohol, scoring between 7 and 23 on a specific screening test for alcohol use disorders. If you are taking medication for alcohol use, that’s okay, as long as your dosage has been stable for the past eight weeks. Participants will need a computer with internet access, a camera, and a microphone to interact with PAHOLA. Throughout the study, you can expect to receive personalized support to help reduce your alcohol use, with the hope that this innovative approach can improve health and well-being for many who have not received help before.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Current drinkers 18 years of age and older who score 7 to 23 on the Alcohol Use Disorders Identification Test
- • 2. Use of medication to treat harmful alcohol use will be allowed provided that the dose has been stable for 8 weeks
- • 3. Availability of a computer with a connection to the internet and a camera and microphone
- Exclusion Criteria:
- • 1. A history of drug use disorders (other than alcohol) in the last two years (except tobacco use disorder)
- • 2. Dose changes of concomitant medications will not be permitted during the study period
- • 3. Pregnant or lactating women, and women of childbearing potential who are not using medically accepted forms of contraception, or women who are planning on becoming pregnant during the study time frame
- • 4. People who are currently reciving psychological treatment for alcohol use disorders
About Centre For Addiction And Mental Health
The Centre for Addiction and Mental Health (CAMH) is Canada’s leading mental health and addiction teaching hospital, dedicated to advancing research, clinical care, and education in the field of mental health. With a commitment to improving the lives of individuals affected by mental illness and addiction, CAMH conducts innovative clinical trials aimed at developing and evaluating new treatment approaches. The institution fosters a collaborative environment that brings together researchers, clinicians, and community partners to translate scientific findings into effective interventions, ensuring the highest standards of care and support for patients. Through its robust research initiatives, CAMH strives to enhance understanding of mental health disorders and promote evidence-based practices in the treatment of addiction and mental health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Kevin Shield
Principal Investigator
Centre for Addiction and Mental Health
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported